PHH2 Share Price Performance
€241.00
56.00 (30.27%)
Price €241.00
Share Price€241.00
PHH2 Community Narratives
There are no narratives available yet.
Recent PHH2 News & Updates
No updates
Paul Hartmann AG Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 30.53
- Gross Margin
- 57.54%
- Net Profit Margin
- 4.47%
- Debt/Equity Ratio
- 17.4%
Paul Hartmann AG Competitors
About PHH2
- Founded
- 1818
- Employees
- 10079
- CEO
- WebsiteView website
Paul Hartmann AG manufactures and sells medical and care products in Germany, rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers body-absorbent products and traditional and modern wound dressings. In addition, the company produce single-use products and solutions for infection; hand, surface, and instrument disinfection; and cleaning, skin care, and skin antisepsis. Further, it offers Link, a platform to learn and exchange medical and clinical knowledge. It sells its products through pharmacies, medical supply stores, and online channels. The company was founded in 1818 and is headquartered in Heidenheim, Germany.
German Market Performance
- 7 Days: 0.4%
- 3 Months: -4.3%
- 1 Year: 21.6%
- Year to Date: 4.8%
In the last week, the market has stayed flat, however the Communication Services sector stood out, gaining 13%. As for the longer term, the market has risen 22% in the past 12 months. As for the next few years, earnings are expected to grow by 17% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading